T-Cell Lymphoma Treatments
Find T-Cell Lymphoma Treatments
Zolinza
What is Zolinza (Vorinostat)?
Approved To Treat
Top Global Experts
Related Clinical Trials
Summary: This is a single-arm, open label, phase 2 study to determine the safety and efficacy of vorinostat without serotherapy as GVHD prophylaxis when combined with either tacrolimus and methotrexate or post-transplant cyclophosphamide, tacrolimus, and mycophenolate in patients aged 1 to 26 years of age with non-malignant disorders undergoing bone marrow transplant following myeloablative conditioning.
Background: Crohn s disease (CD) is an inflammatory bowel disease. It causes inflammation of the gut. Symptoms may include diarrhea, abdominal pain, fatigue, weight loss and malnutrition. CD has no cure, but symptoms can sometimes be controlled with medicine. Researchers want to see if it is safe to treat CD with the medicine vorinostat. It is thought that vorinostat may reduce the inflammation process of CD....
Summary: The study is an exploratory evaluation of the safety and efficacy of vorinostat in Pitt Hopkins syndrome. Each patient will be self-controlled in an adapted N-of-1 study design methodology with three treatment arms, including a 4-week placebo phase and two vorinostat dose arms, including every 8 weeks of daily dosing at a low dose of 80mg/m2/day and 8 weeks of a higher dose at 160mg/m2/day. Key ob...
Related Latest Advances
Brand Information
- Thromboembolism
- Myelosuppression
- Gastrointestinal Toxicity
- Hyperglycemia
- Clinical Chemistry Abnormalities
- Severe thrombocytopenia when combined with other Histone Deacetylase (HDAC) Inhibitors




